oa Pravastatin Induced Myopathy

References

1. Farmer JA. Learning from the cerivastatin experience (commentary). Lancet. 2001; 358::13835.
   [Google Scholar]
2. Grundy SM. Can statins cause chronic low-grade myopathy ? Ann Intern Med. 2002; 137::617.
   [Google Scholar]
3. Grundy SM. HMG CO A reductase inhibitor for treatment of hypercholestrelimia. N Engl J Med. l998 Jul 7; 319:1:24–33.
   [Google Scholar]
4. Hansen KE, Hildebrand JP, Furguson EE. JH Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005 Dec 12-26; 165:22:2671–2676.
   [Google Scholar]
5. Tobert JA. Efficacy and long-term adverse effect pattern of lovastatin. Am J Cardiol. 1988 Nov 11; 62:15:28J–34J.
   [Google Scholar]
6. The Pink Sheet” FDC Reports. 2002; 64 (Vol 23): 5.
7. Pfeffer MA, Keech A, Sacks FM, Cobbe SM, Tonkin A, Byington RP, Davis BR, Friedman CP, Braunwald E. Safety and tolerability of pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) Project. Circulation. 2002 May 21; 105:20:2341–2346.
   [Google Scholar]
8. Gadbut AP, Caruso AP, Galper JB. Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin. J Mol Cell Cardiol. 1995 Oct; 27:10:2397–2402.
   [Google Scholar]